MedTrace Logo

Onco-Genomas Brasil: Mapping Breast and Prostate Cancer in the Brazilian Public Health System

NCT05306600 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 882

Last updated 2026-02-13

No results posted yet for this study

Summary

This project aims to perform complete sequencing of the somatic (tumor) and germline exomes during clinical investigation of cancer patients treated through the Brazilian Unified Health System to generate genomic and phenotypic data for the Brazilian Ministry of Health's National Precision Genomics and Health Program, called Genomas Brasil, as well as to collect data on the population's ancestry.

Conditions

Interventions

DIAGNOSTIC_TEST

whole exome and whole genome sequencing analysis

Somatic and germline whole exome sequencing will be analyzed for prostate and HER2-positive breast cancer Somatic whole exome and germline whole genome sequencing will be analyzed for triple-negative breast cancer

Sponsors & Collaborators

  • Ministry of Health, Brazil

    collaborator OTHER_GOV

  • Hospital Moinhos de Vento

    lead OTHER

Principal Investigators

  • Daniela D Rosa, PhD · Hospital Moinhos de Vento

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-09
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05306600 on ClinicalTrials.gov